Validation of the CPS+EG and Neo-Bioscore staging systems after preoperative systemic therapy for breast cancer in a single center in China.

CONCLUSIONS: The CPS + EG staging system and Neo-Bioscore can improve prognostic prediction in non-pCR breast cancer patients after PST and, provided unfavorable prognostic factors such as insufficient treatment are incorporated, will have broader clinical applicability. PMID: 29677568 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29677568?dopt=Abstract

Source: Breast - April 17, 2018 Category: Cancer & Oncology Authors: Xu L, Duan X, Zhou B, Liu Y, Ye J, Liu Z, Ma C, Zhang H, Zhang S, Zhang L, Zhao J, Cheng Y Tags: Breast Source Type: research